Toggle Main Menu Toggle Search

Open Access padlockePrints

Senescence Markers and Associated Transcriptomic Changes Are Expressed at Early Stages of Alzheimer’s Neuropathology but Are Not Independently Related to Dementia

Lookup NU author(s): Dr Connor Richardson

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2026 by the authors.Cellular senescence may affect the post-mitotic cells of the brain. We examined the expression of senescence markers, including p16, p21, γH2Ax and H3K9me3, in the frontal cortex of brain donations from the Cognitive Function and Ageing Study to assess their relationship to Alzheimer’s disease neuropathological change (ADNC) and dementia. p21, γH2Ax and H3K9me3 were expressed in pyramidal neurons and glia, whilst p16 was confined to glial cells. p21 and γH2Ax were correlated in neurons, and with p16 in glia. They did not increase with ADNC, tending to be higher at early Braak neurofibrillary tangle stages. Transcriptomic profiling of pyramidal neuron-enriched samples at low Braak stages showed that higher neuronal p21 expression was associated with altered pathways for neuronal function, neurodegeneration, protein homeostasis, mitochondrial dysfunction and synaptic signalling. In conclusion, the different expression profile of senescence markers in neurons and glia suggest possible differences in senescence-related mechanisms. Expression at lower ADNC stages suggests senescence may be important at earlier stages of Alzheimer’s pathogenesis, whilst transcriptomic changes suggest an impact on neuronal function. The lack of association of senescence markers with dementia status indicates that more work is needed to determine the value of senescence as a therapeutic target for dementia.


Publication metadata

Author(s): Vazquez-Villasenor I, Benson B, Richardson CD, Waller R, Castelli LM, Simpson JE, Matthews FE, Brayne C, Wharton SB

Publication type: Article

Publication status: Published

Journal: International Journal of Molecular Sciences

Year: 2026

Volume: 27

Issue: 15

Online publication date: 03/08/2026

Acceptance date: 30/07/2026

Date deposited: 25/08/2026

ISSN (print): 1661-6596

ISSN (electronic): 1422-0067

Publisher: Multidisciplinary Digital Publishing Institute (MDPI)

URL: https://doi.org/10.3390/ijms27156964

DOI: 10.3390/ijms27156964

Data Access Statement: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to ethical restrictions of CFAS.

PubMed id: 42589618


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Alzheimer’s Research UK (ARUK PG2013A-003)
MRC(MRC/G990 1400, U.1052.00.0013, G0900582)
National Institute for Health and Care Research (NIHR)

Share